A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)

PHASE3CompletedINTERVENTIONAL
Enrollment

383

Participants

Timeline

Start Date

August 24, 2017

Primary Completion Date

March 14, 2019

Study Completion Date

November 18, 2019

Conditions
Arthritis, Psoriatic
Interventions
DRUG

Guselkumab

Participants will receive 100mg of guselkumab as a sterile liquid for SC injection.

DRUG

Placebo

Participants will receive matching placebo as SC injection.

Trial Locations (95)

105

Chang Kung Memorial Hospital, Taipei

333

Chang-Gung Memorial Hospital, LinKou Branch, Taoyuan District

402

Chung Shan Medical University Hospital, Taichung

704

National Cheng Kung University Medical Center, Tainan City

833

Chang Gung Memorial Hospital Kaohsiung Branch, Kaohsiung City

970

Hualien Tzu Chi Hospital, Hualien City

1023

Orszagos Reumatologia es Fizioterapias Intezet, Budapest

1062

Magyar Honvedseg Egeszsegugyi Kozpont, Budapest

2143

Pest Megyei Flor Ferenc Korhaz, Kistarcsa

2170

Liverpool Hospital, Liverpool

3128

Eastern Health - Box Hill Hospital, Melbourne

3220

Barwon Rheumatology Services, Geelong

4032

Debreceni Egyetem Klinikai Kozpont, Debrecen

4558

Rheumatology Research Unit, Maroochydore

5011

Queen Elizabeth Hospital, Woodville South

7000

Southern Clinical Research, Hobart

7061

SMG - SNU Boramae Medical Center, Seoul

9700

Martinus Medicus Health Center, Szombathely

10002

National Taiwan University Hospital, Taipei

10789

ISA GmbH, Berlin

10990

Hospital Pulau Pinang, George Town

12850

Revmatologicky ustav, Prague

13620

Seoul National University Bundang Hospital, Bundang

14000

Revmatologicka ambulance, Prague

15006

Hosp. Univ. A Coruña, A Coruña

15706

Hosp. Clinico Univ. de Santiago, Santiago de Compostela

16499

Ajou University Hospital, Suwon

20095

MVZ Rheuma, Hamburg

28007

Hosp. Gral. Univ. Gregorio Marañon, Madrid

28034

Hosp. Univ. Ramon Y Cajal, Madrid

29009

Hospital Regional Carlos Haya, Málaga

30990

Hospital Raja Permaisuri Bainun, Ipoh

35205

Rheumatology Associates, Birmingham

41010

Hosp. Infanta Luisa, Seville

42105

Krankenhaus St. Josef, Wuppertal

44649

Rheumazentrum Ruhrgebiet, Herne

46940

Hosp. de Manises, Valencia

48109

University of Michigan, Ann Arbor

60590

Universitatsklinikum Frankfurt, Frankfurt

61029

Communal Institution of Health Kharkiv City multifield hospital №18, Kharkiv

61141

Revmaclinic, Brno

63141

Arthritis Consultants, St Louis

65025

Municipal Non-profit Enterprise 'Odesa Regional Clinical Hospital' Odesa Regional Council, Odesa

68100

Hospital Selayang, Batu Caves

68601

Medical Plus S.R.O., Uherské Hradiště

70300

Hospital Tuanku Jaafar, Seremban

70800

MUDr. Rosypalova, s.r.o, Ostrava

75400

Hospital Melaka, Malacca

76001

PV-Medical S.R.O, Zlín

81362

Kaohsiung Veterans General Hospital, Kaohsiung City

85210

Arizona Arthritis & Rheumatology Research, PLLC, Mesa

85306

Arizona Arthritis & Rheumatology Associates PC, Glendale

150003

Clinical Emergency Hospital n.a. N.V. Solovyev, Yaroslavl

150023

Clinical Hospital #10, Yaroslavl

162600

Medical and Sanitary Unit ''Severstal'', Cherepovets

344007

Rostov Regional Clinical Dermatovenerological Dispensary, Rostov

390046

Ryazan Regional Clinical Dermatovenerological Dispensary, Ryazan

398005

Lipetsk Regional Dermatovenerological Dispensary, Lipetsk

414014

Hosp. Unv. de Valme, Seville

450005

Republican Clinical Hospital - G.G. Kuvatov, Ufa

454092

Chelyabinsk Regional Clinical Dermatovenerological Dispensary, Chelyabinsk

620076

Research Institute of Dermatovenerology, Immunology, Yekaterinburg

660022

Krasnoyarsk State Medical University, Krasnoyarsk

06810

Clinical Research Center of Connecticut, Danbury

46256-4697

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

07728

Arthritis and Osteoporosis Associates, Freehold

78731-3146

Austin Regional Clinic, Austin

A1C 5B8

Eastern Regional Health Authority, St. Clare's Mercy Hospital, St. John's

L4M 6L2

The Waterside Clinic, Barrie

L8N 1Y2

Dermatrials Research, Hamilton

K9J 5K2

Skin Centre for Dermatology, Peterborough

N2J 1C4

K. Papp Clinical Research, Waterloo

G1V 3M7

G.R.M.O. (Groupe de recherche en maladies osseuses) Inc., Québec

15-351

Nzoz Osteo-Medic, Bialystok

85-168

Szpital Uniwersytecki Nr 2 w Bydgoszczy, Bydgoszcz

62-069

NSZOZ Unica CR, Dąbrówka

82-300

Centrum Kliniczno Badawcze J. Brzezicki, B. Gornikiewicz-Brzezicka Lekarze Spolka Partnerska, Elblag

10-117

Etyka Osrodek Badan Klinicznych, Olsztyn

60-218

Centrum Medyczne Hetmańska, Poznan

87-100

Nasz Lekarz Przychodnie Medyczne, Torun

00-874

Medycyna Kliniczna, Warsaw

02-637

Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im. prof. dr hab. med. Eleonory Reicher, Warsaw

51-685

Centrum Medyczne WroMedica, Wroclaw

53-224

Nzoz Biogenes Sp. Z O. O., Wroclaw

04763

Hanyang University Hospital for rheumatic Diseases, Seoul

06591

The Catholic University of Korea Seoul St. Mary's Hospital, Seoul

08003

Hosp. Del Mar, Barcelona

Unknown

Municipal health care institution Chernihiv Regional Hospital, Chernihiv

Ivano-Frankivsk National Medical University, Ivano-Frankivsk City Clinical Hospital, Ivano-Frankivsk

Municipal Institution Regional hospital-center of emergency care and disasters medicine, Kharkiv

Khmelnitckiy regional hospital, Khmelnytsky

Clinic of SI 'NSC 'The M.D.Strazhesko Institute of Cardiology' of NAMS of Ukraine', Kyiv

Kyiv Railway Station Clinical Hospital #2, Kyiv

Danylo Halytsky Lviv National Medical University, Lviv

Municipal institution of Tepnopil Regional Council 'Ternopil University Hospital', Ternopil

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT03162796 - A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s) | Biotech Hunter | Biotech Hunter